RxDoctor Payments Data

Scott Carrington

Podiatrist · la Crosse, WINPI 1366885485

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $83,181 of the $115,716 with a category attached, or 71.9%. 22 manufacturers reported payments, led by Linvatec Corporation at 42.8% of the total. 2025 is the largest year on record at $47,689, more than ten times the $1,711 reported in 2019. Among podiatrist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,716in general payments, 2019–2025

Across 179 payments — averaging $646.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$50K
  • Stryker$39K
  • Medical Device Business Services, Inc.$21K
  • Medshape, Inc.$3K
  • Johnson & Johnson$2K
  • Paragon 28, Inc.$399
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$83,18172%
  • Grants$5,0004%
  • Travel & lodging$21,17118%
  • Food & beverage$5,6595%
  • Gifts$7051%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,716 in reported general payments places this provider in the 95th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$55,697
Medicare patients
187
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin33$229
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$228
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen44$150
Methylprednisolone16$86
Cyclobenzaprine Hcl17$79
Tramadol Hcl19$38
Oxycodone Hcl11$26

Paid to pharmacies, not to this prescriber.

Other podiatrist in la Crosse

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →